Subsequently, these five LncRNAs were subjected to differential expression analysis and survival prognosis analysis, which showed that TRIM52-AS1 was significantly downregulated in CC (Figure 8F), and its high level of expression indicated a considerable survival advantage (Figure 8G). This evidence concerns the gene TRIM52 and cholangiocarcinoma.